[Gentamicin-susceptibility of various pathogens isolated from clinical materials].

We studied on the antibacterial activity of gentamicin against various pathogens isolated from clinical materials mainly isolated during 1974 and 1975, comparing with other antibiotics. Beta hemolytic streptococci, pneumococci and enterococci are less susceptible to gentamicin than staphylococci. Staph, aureus and Staph.

[Distribution and changes of antibiotic susceptibility of genus Haemophilus (author's transl)].

We studied on the distribution and changes of antibiotic susceptibility of H. influenzae, H. parainfluenzae and H.

[Changes of antimicrobial susceptibility of anaerobic bacteria from clinical specimens (author's transl)].

The susceptibility to several commonly used antimicrobial agents was examined on approximately 900 isolates of various anaerobes from clinical specimens between October 1965 to May 1975, and the changes of susceptibility were investigated. Antimicrobial agents tested were penicillin G (PC-G), ampicillin (AB-PC), cephaloridine (CER), erythromycin (EM), josamycin (JM), lincomycin (LCM), clindamycin (CLDM), chloramphenicol (CP) and tetracycline (TC). And thiamphenicol (TP) and doxycycline (DOTC) were also used against recently isolated organisms.

[Comparison of the antibacterial activity of amikacin (BB-K8) with other aminoglycosides against pathogens recently isolated from clinical materials (author's transl) ].

We determined the antibacterial activity of amikacin against 1,277 strains of pathogenic bacteria isolated from clinical materials during 1974, including beta hemolytic streptococci, pneumococci, enterococci, Staphylococcus aureus, Staph. epidermidis, Escherichia coli, Klebsiella, Enterobacter, Citrobacter, Serratia, Proteus morganii and Pseudomonas aeruginosa, and compared the minimum inhibitory concentration (MIC) of this drug with gentamicin, dibekacin, tobramycin and kanamycin. 1)Antibacterial activity of amikacin against beta hemolytic streptococci, pneumococci and enterococci was as weak as the other four aminoglycosides, but against Staph.

[Multiple drug resistance of Enterobacter-Serratia group isolated from clinical materials (author's transl)].

We determined the drug susceptibility of Serratia-Enterobacter group isolated from clinical materials between October 1973 and May 1974 by disk method and agar plate dilution method, and compared the drug susceptibility and multiple resistance among pigment-producing Serratia, pigment non-producing Serratia and Enterobacter. We used following drugs for susceptibility tests; ampicillin, carbenicillin, sulbenicillin, cephaloridine, streptomycin, kanamycin, dibekacin, gentamicin, chloramphenicol, tetracycline, colistin, nalidixic acid, nitrofurantoin and erythromycin. Above one half of strains of Serratia and Enterobacter was isolated from sputa and pharyngeal swabs.